Clinical trial

Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer

NCT05620342

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2023-06-21

PhaseEARLY_PHASE1

Study timeline

Study start (actual)2023-06-21Date precision: day

Registry last updated2026-02-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Small Cell Lung Carcinomaunresolved

Non Small Cell Lung Cancerunresolved

Interventions

iC9.GD2.CAR.IL-15 T InfusionBIOLOGICAL

Sponsors & collaborators

UNC Lineberger Comprehensive Cancer Centerlead sponsor

Bellicum Pharmaceuticalscollaborator

United States Department of Defensecollaborator

M.D. Anderson Cancer Centercollaborator

Mapped research locations

Chapel HillNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05620342 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.